Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Compulsory license stymied

The World Trade Organization has failed for the third time to come up with a mechanism under which international trade regulations could be modified to allow poor countries that lack pharmaceutical manufacturing to import medicines under compulsory licenses. Instead, they have asked an advisory council to come up with recommendations by year end.

Last month's WTO meeting once

Read the full 576 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE